Author:
Caocci G,Atzeni S,Orrù N,Azzena L,Martorana L,Littera R,Ledda A,La Nasa G
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference8 articles.
1. Baccarani M, Saglio J, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, et al., European Leukemia Net. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2006; 108: 1809–1820.
2. Kantarjian H, Pasquini R, Hamerschlak N, Rousselot P, Holowiecki J, Jootar S et al. Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial. Blood 2007; 109: 5143–5150.
3. Basciani S, Mariani S, Arizzi M, Ulisse S, Rucci N, Jannini EA et al. Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and –beta during human testicular development and disease. J Clin Endocrinol Metab 2002; 87: 2310–2319.
4. Cheng J, Watkins SC, Walker WH . Testosterone activates mitogen-activated protein kinase via Src kinase and the epidermal growth factor receptor in Sertoli cells. Endocrinology 2007; 148: 2066–2074.
5. Gambacorti-Passerini C, Tornaghi L, Cavagnini F, Rossi P, Pecori-Giraldi F, Mariani L et al. Gynaecomastia in men with chronic myeloid leukemia after imatinib. Lancet 2003; 361: 1954–1956.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献